These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2790126)

  • 1. Significance tests for cancer screening trials.
    Tarone RE; Gart JJ
    Biometrics; 1989 Sep; 45(3):883-90. PubMed ID: 2790126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential contribution of screening to cancer mortality reduction.
    Hakama M
    Cancer Detect Prev; 1993; 17(4-5):513-20. PubMed ID: 8242651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of service screening on breast cancer mortality rates.
    Cox B
    Eur J Cancer Prev; 2008 Aug; 17(4):306-11. PubMed ID: 18562953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A likelihood ratio test for cancer screening trials.
    Self SG; Etzioni R
    Biometrics; 1995 Mar; 51(1):44-50. PubMed ID: 7766795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of mammography on U.S. breast cancer mortality, 1975-2000: are intermediate outcome measures informative?
    Habbema JD; Tan SY; Cronin KA
    J Natl Cancer Inst Monogr; 2006; (36):105-11. PubMed ID: 17032900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early findings from a community-based, cluster-randomized, controlled oral cancer screening trial in Kerala, India. The Trivandrum Oral Cancer Screening Study Group.
    Sankaranarayanan R; Mathew B; Jacob BJ; Thomas G; Somanathan T; Pisani P; Pandey M; Ramadas K; Najeeb K; Abraham E
    Cancer; 2000 Feb; 88(3):664-73. PubMed ID: 10649262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Gothenburg Breast Screening Trial.
    Bjurstam N; Björneld L; Warwick J; Sala E; Duffy SW; Nyström L; Walker N; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Salander H; Säve-Söderbergh J; Wahlin T
    Cancer; 2003 May; 97(10):2387-96. PubMed ID: 12733136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geographic association between mammography use and mortality reduction in the US.
    Das B; Feuer EJ; Mariotto A
    Cancer Causes Control; 2005 Aug; 16(6):691-9. PubMed ID: 16049808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonparametric estimation of asymptomatic duration from a randomized prospective cancer screening trial.
    Shen Y; Huang X
    Biometrics; 2005 Dec; 61(4):992-9. PubMed ID: 16401272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Screening for cancer].
    Bjørge T; Tropé CG; Engeland A
    Tidsskr Nor Laegeforen; 1999 Mar; 119(8):1129-36. PubMed ID: 10228417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and tumor characteristics of breast cancer diagnosed before and after implementation of a population-based screening-program.
    Hofvind S; Sørum R; Thoresen S
    Acta Oncol; 2008; 47(2):225-31. PubMed ID: 17851868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the age to begin periodic breast cancer screening using data from a few regularly scheduled screenings.
    Baker SG
    Biometrics; 1998 Dec; 54(4):1569-78. PubMed ID: 9883553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An adaptive weighted log-rank test with application to cancer prevention and screening trials.
    Self SG
    Biometrics; 1991 Sep; 47(3):975-86. PubMed ID: 1742450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
    Schröder FH
    Can J Urol; 2005 Feb; 12 Suppl 1():2-6; discussion 92-3. PubMed ID: 15780157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer screening: a different look at the evidence.
    Wright CJ
    Surgery; 1986 Oct; 100(4):594-8. PubMed ID: 3764685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in breast cancer mortality in Navarre (Spain) after introduction of a screening programme.
    Ascunce EN; Moreno-Iribas C; Barcos Urtiaga A; Ardanaz E; Ederra Sanz M; Castilla J; Egüés N
    J Med Screen; 2007; 14(1):14-20. PubMed ID: 17362566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of cancer screening from the epidemiologic point of view].
    Oshima A
    Gan No Rinsho; 1989 Jan; 35(2):253-7. PubMed ID: 2649707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screen test update, program activity, and cancer detection rates.
    AARN News Lett; 1992 Jun; 48(6):31. PubMed ID: 1636367
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.